EUVIMEDEUVIMED entdecken
Kohortenstudie

Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China

Dawei Huang, Xiaoyuan Zhong, Yuxiong Jiang, Luyang Kong, Rui Ma iD, Jiajing Lu, Ying Li, Yuling Shi iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae147 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Dawei Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Psoriasis, Insulin Resistance. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis and insulin resistance (IR) are closely related, but it remains unclear whether IR affects the treatment of patients with psoriasis.

Objective

To investigate whether IR impairs the treatment response to biologic agents in patients with moderate-to-severe plaque psoriasis.

Methods

This project was based on a prospective cohort study design. Data were collected from the Shanghai Psoriasis Effectiveness Evaluation CoHort (SPEECH), which is a prospective cohort exploring treatment strategies for psoriasis in China. IR was assessed using triglyceride glucose–body mass index (TyG-BMI). Psoriasis severity was assessed using Psoriasis Area and Severity Index (PASI) and Physician Global Assessment (PGA). Multiple logistic regression was used to explore the differences between patients with high and low levels of IR. Subgroup and sensitivity analyses were performed to examine the robustness of the study results.

Results

A total of 290 patients were included in the analysis. Based on median TyG-BMI, the patients were divided into two groups: high and low IR. The high IR group exhibited a higher prevalence of diabetes, a higher BMI, and higher fasting blood glucose and triglyceride levels than the low IR group. Further analysis of treatment efficacy revealed that patients in the high IR group had lower PASI 75 [≥ 75% improvement in Psoriasis Area and Severity Index (PASI)], PASI 90 (≥ 90% improvement in PASI) and PGA 0/1 (‘clear’ or ‘almost clear’) response rates after 12 weeks of treatment. In the low IR group, 81.9% of patients achieved PASI 75, 58.3% achieved PASI 90 and 75.7% achieved PGA 0/1. However, the proportion of responses at each endpoint was significantly lower in the high IR group compared with the low IR group. The reduced PGA 0/1 response rate was more significant in the high IR group, indicated by lower odd ratios. Subsequent subgroup and sensitivity analyses produced consistent results.

Conclusion

IR is associated with lower effectiveness of biologics in patients with psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisInsulin ResistanceHumansProspective StudiesMaleFemaleMiddle AgedChinaAdultTreatment OutcomeBiological ProductsSeverity of Illness IndexBlood GlucoseBody Mass IndexDermatologic Agents

Substanzen

Biological ProductsBlood GlucoseDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Institute of Psoriasis, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Rui Ma, Yuling Shi

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Innovation Program of Shanghai Municipal Education Commission
  • Clinical Research Plan of SHDC
  • Program of Shanghai Academic Research Leader
  • Shanghai Municipal Health Commission Project
  • China Postdoctoral Science Foundation
  • Municipal Hospital Diagnosis and Treatment Technology Promotion and Optimization Management Project of SHDC

Zitieren

APA

Huang, D., Zhong, X., Jiang, Y., Kong, L., Ma, R., Lu, J., Li, Y., & Shi, Y. (2024). Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae147

Vancouver

Huang D, Zhong X, Jiang Y, Kong L, Ma R, Lu J, et al. Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae147

BibTeX
@article{Huang2024,
  author = {Huang, Dawei and Zhong, Xiaoyuan and Jiang, Yuxiong and Kong, Luyang and Ma, Rui and Lu, Jiajing and Li, Ying and Shi, Yuling},
  title = {Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae147}
}
Kostenlos starten →